Free tool
FAERS Monitor: Tyvaso Dpi
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 214324 or its brand name (Tyvaso Dpi, Treprostinil). Reports on generic versions are filed under their own applications.
Reports
17,039
Serious
9,139
54% of reports
Hospitalization
6,069
Death reported
1,531
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- cough3,755
- dyspnoea3,545
- headache3,034
- diarrhoea2,400
- dizziness1,892
- fatigue1,876
- nausea1,861
- oxygen saturation decreased1,205
- hypotension1,102
- vomiting905
- dyspnoea exertional898
- throat irritation822
- death784
- asthenia773
- weight decreased766
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2005 | 1 |
| 2006 | 3 |
| 2007 | 1 |
| 2008 | 2 |
| 2009 | 8 |
| 2010 | 13 |
| 2011 | 22 |
| 2012 | 40 |
| 2013 | 42 |
| 2014 | 71 |
| 2015 | 146 |
| 2016 | 90 |
| 2017 | 103 |
| 2018 | 101 |
| 2019 | 456 |
| 2020 | 481 |
| 2021 | 624 |
| 2022 | 1,250 |
| 2023 | 3,218 |
| 2024 | 3,476 |
| 2025 | 4,083 |
| 2026 | 2,808 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,037,120 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| dyspnoea exertionalSignal | 898 | 30.1 | 28.2 | 24,699 |
| oxygen saturation decreasedSignal | 1,205 | 27.0 | 25.6 | 29,606 |
| throat irritationSignal | 822 | 23.0 | 21.5 | 17,011 |
| coughSignal | 3,755 | 16.7 | 16.3 | 55,551 |
| dyspnoeaSignal | 3,545 | 7.8 | 7.5 | 21,357 |
| hypotensionSignal | 1,102 | 6.8 | 6.4 | 5,483 |
| headacheSignal | 3,034 | 6.0 | 5.8 | 12,955 |
| dizzinessSignal | 1,892 | 4.7 | 4.5 | 5,613 |
| diarrhoeaSignal | 2,400 | 4.6 | 4.4 | 6,953 |
| weight decreasedSignal | 766 | 3.4 | 3.2 | 1,305 |
| fatigueSignal | 1,876 | 3.0 | 2.9 | 2,553 |
| nauseaSignal | 1,861 | 2.9 | 2.8 | 2,411 |
| astheniaSignal | 773 | 2.5 | 2.4 | 732 |
| vomitingSignal | 905 | 2.4 | 2.2 | 737 |
| death | 784 | 1.1 | 1.0 | 11 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.